Cornerstone Therapeutics Inc. (Nasdaq: CRTX) had received a Warning Letter from the Food and Drug Administration ("FDA") alleging that its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE